Can TPO and Tg antibodies indicate autoimmune thyroid activity that raises systemic inflammation even when TSH is normal?

An objective, evidence-based assessment of the relationship between thyroid antibodies, thyroid status, and systemic inflammation indicates that active autoimmune thyroid processes can impact systemic physiology independently of thyroid metabolic status.

Clinical and immunological evidence

Clinical studies consistently demonstrate that elevated titers of thyroid peroxidase antibodies (TPOAb) and thyroglobulin antibodies (TgAb) serve as highly sensitive biomarkers of active, localized autoimmune processes within the thyroid gland, even in individuals with normal thyroid-stimulating hormone (TSH) levels (euthyroidism).

• In individuals with normal TSH, the presence of TPOAb and TgAb correlates with significant lymphocytic infiltration and structural follicle disruption within the thyroid.
• Clinical cohorts confirm that euthyroid individuals with positive thyroid antibodies have statistically significant elevations in systemic inflammatory markers. Specifically, those with positive antibodies show higher levels of systemic pro-inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-α), interferon-gamma (IFN-γ), and interleukin-6 (IL-6), compared to antibody-negative, euthyroid controls.
• Patients who are biochemically euthyroid but antibody-positive frequently exhibit elevated blood count-derived inflammation indices and higher levels of systemic oxidative stress markers, demonstrating that a normal TSH does not indicate a quiet or inactive immune environment.

Mechanistic explanations

The connection between thyroid autoimmunity and systemic inflammatory tone is driven by specific immunopathways and secondary systemic alterations:

• Cytokine spillover: The chronic autoimmune reaction inside the thyroid tissue involves the recruitment of T-helper 1 (Th1) and Th17 lymphocytes. These cells secrete large amounts of localized TNF-α, IFN-γ, and IL-6. This localized cytokine pool spills over into the systemic circulation, raising general inflammatory tone.
• Intestinal barrier dysfunction: Active thyroid autoimmunity has been linked to compromised mucosal barriers. Studies indicate that patients with elevated TPOAb exhibit significantly higher levels of serum zonulin—a clinical biomarker of tight junction disassembly—which correlates directly with TPOAb titers. Increased intestinal permeability (leaky gut) can allow luminal antigens into the bloodstream, further driving systemic low-grade inflammation.

Bottom line

Thyroid peroxidase and thyroglobulin antibodies are direct indicators of active thyroid autoimmunity. This immunological activity promotes low-grade systemic inflammation, cytokine activation, and mucosal barrier disruption independently of thyroid metabolic status, occurring even in the presence of completely normal TSH levels.